Roche plans to di­vest from lega­cy Genen­tech man­u­fac­tur­ing fa­cil­i­ty in Cal­i­for­nia

Roche is plan­ning to make some changes to its sub­sidiary’s man­u­fac­tur­ing net­work in Cal­i­for­nia.

The Swiss phar­ma an­nounced Wednes­day that it plans to di­vest from Genen­tech’s man­u­fac­tur­ing fa­cil­i­ty in Va­cav­ille, CA, around 58 miles north­east of San Fran­cis­co. Ac­cord­ing to a state­ment from Roche, the move is part of a “broad­er strat­e­gy” to bring its man­u­fac­tur­ing ca­pa­bil­i­ties in line with its fu­ture pipeline. Roche is start­ing the process of find­ing a buy­er for the site but has not named any can­di­dates yet.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER